Lanean...
Structurally Based Design of Glucagon Mutants that Inhibit Fibril Formation
The peptide hormone glucagon is prescribed as a pharmaceutical compound to treat diabetic hypoglycemia. However, at the acidic pH where it is highly soluble, glucagon rapidly aggregates into inactive and cytotoxic amyloid fibrils. The recently determined high-resolution structure of these fibrils re...
Gorde:
| Argitaratua izan da: | Biochemistry |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8254510/ https://ncbi.nlm.nih.gov/pubmed/34124902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.biochem.1c00214 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|